BIOMAT Database Logo BIOMAT Database Logo

Relative importance of estrogen and progesterone receptor assays as prognostic indicators in primary breast cancer: a short-term study. 1989

D Brocklehurst, and C E Wilde, and J A Finbow, and R Brett, and A E Champion, and D G Dewhurst
Department of Clinical Chemistry, Doncaster Royal Infirmary, U.K.

This short-term study of the relative importance of estrogen and progesterone receptors shows that progesterone receptor correlates better than estrogen receptor with tumor recurrence regardless of lymph-node status. Life-table analysis has effectively identified only two groups of patients that may be classified by progesterone receptor status alone. Progesterone-receptor negativity correlated well with tumors of histological Grade III; estrogen-receptor positivity correlated with Grade I and II tumors. The earlier recurrence of Grade III breast tumors may explain why progesterone receptor is a better prognostic indicator than estrogen receptor in short-term studies.

UI MeSH Term Description Entries
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D011980 Receptors, Progesterone Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives. Progesterone Receptors,Progestin Receptor,Progestin Receptors,Receptor, Progesterone,Receptors, Progestin,Progesterone Receptor,Receptor, Progestin
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D Brocklehurst, and C E Wilde, and J A Finbow, and R Brett, and A E Champion, and D G Dewhurst
The importance of estrogen and progesterone receptor in primary breast cancer.
January 1983, Progress in clinical and biological research,
D Brocklehurst, and C E Wilde, and J A Finbow, and R Brett, and A E Champion, and D G Dewhurst
[Estrogen receptor and progesterone receptor as a prognostic indicator of breast cancer].
March 1988, Nihon Gan Chiryo Gakkai shi,
D Brocklehurst, and C E Wilde, and J A Finbow, and R Brett, and A E Champion, and D G Dewhurst
Breast cancer: estrogen and progesterone receptor assays as a guide to therapy.
January 1983, Mayo Clinic proceedings,
D Brocklehurst, and C E Wilde, and J A Finbow, and R Brett, and A E Champion, and D G Dewhurst
Estrogen receptor quantitation and staging as complementary prognostic indicators in breast cancer: a study of 583 patients.
December 1981, International journal of cancer,
D Brocklehurst, and C E Wilde, and J A Finbow, and R Brett, and A E Champion, and D G Dewhurst
Prognostic Significance of Single Progesterone Receptor Positivity: A Comparison Study of Estrogen Receptor Negative/Progesterone Receptor Positive/Her2 Negative Primary Breast Cancer With Triple Negative Breast Cancer.
November 2015, Medicine,
D Brocklehurst, and C E Wilde, and J A Finbow, and R Brett, and A E Champion, and D G Dewhurst
Estrogen receptor-alpha mRNA in primary breast cancer: relationship to estrogen and progesterone receptor proteins and other prognostic factors.
March 2002, Asian Pacific journal of allergy and immunology,
D Brocklehurst, and C E Wilde, and J A Finbow, and R Brett, and A E Champion, and D G Dewhurst
Prognostic value of estrogen and progesterone receptors in primary breast cancer.
January 1983, Breast cancer research and treatment,
D Brocklehurst, and C E Wilde, and J A Finbow, and R Brett, and A E Champion, and D G Dewhurst
Estrogen and progesterone receptors as prognostic factors in breast cancer.
February 1988, Tumori,
D Brocklehurst, and C E Wilde, and J A Finbow, and R Brett, and A E Champion, and D G Dewhurst
Progesterone and estrogen receptors as prognostic variables in breast cancer.
June 1983, Cancer research,
D Brocklehurst, and C E Wilde, and J A Finbow, and R Brett, and A E Champion, and D G Dewhurst
Estrogen and progesterone receptor profile patterns in primary breast cancer.
January 1983, Breast cancer research and treatment,
Copied contents to your clipboard!